InterVene
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2684 Middlefield Rd Ste E, Redwood City,...Phone Number
(650) 995-7137Website
www.intervene-med.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About InterVene
InterVene, Inc., located in Redwood City, Calif., in the San Francisco Bay Area, was formed with assistance from the Stanford Biodesign Fellowship program and was a former Company-In-Residence at the Fogarty Institute for Innovation. Staffed by highly experienced interventional cardiovascular professionals and advised by accomplished venous thought-leading physicians, the company develops interventional technology for treatment and prophylaxis of the causes of CVI with a specific interest in deep veins and the more severe, challenging aspects of venous disease.Explore more
InterVene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InterVene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once InterVene has new funding data
Congratulate Masked Content for being promoted to Masked Content at InterVene
Check if InterVene has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
InterVene, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on InterVene recently announced quarterly report
Check out if InterVene is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if InterVene had a recent Job posting/layoffs
Product Launch: Get notified when InterVene launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to InterVene
Compare insights from companies similar to InterVene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InterVene is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InterVene is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InterVene.
InterVene financials insights
Gather financial insights about InterVene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$13M
InterVene Tech Stack
A closer look at the technologies used by InterVene
Most Recent Scoops
Person-Based
Person-Based
Funding
Funding
Facilities Relocation / Expansion
InterVene is planning to move its offices in January 2023. The move will impact approximately 10 employees at their existing office located at 415 Grand Ave, South San Francisco, CA.
Funding
Funding
InterVene News & Media
InterVene’s BlueLeaf Endovenous Valve Formation (EVF) System Granted Breakthrough Device Designation by the FDA
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVene’s BlueLeaf® System receives FDA Breakthrough Device Designation as first catheter-based solution for DVR without need for an implant.InterVene Raises $15M in Series B Funding
InterVene Inc., a South San Francisco, CA-based developer of a catheter-based system to correct deep vein valve failure, raised $15m in Series B financing round. The round was led by new investor 3×5 Partners, who was joined by prior investors RiverVest Venture Partners®, Boston Scientific Corporation (NYSE: BSX), Correlation Ventures and others. The company will […] The post InterVene Raises $15M in Series B Funding appeared first on FinSMEs.InterVene Raises $15 Million in Series B Funding for First Catheter-Based System to Correct Deep Vein Valve Failure
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--InterVene Inc. has raised $15 million for its BlueLeaf® Endovenous Valve Formation System, the first catheter-based solution for deep vein reflux.InterVene Scoops Up $15M Series B Funding
SOUTH SAN FRANCISCO, CA, InterVene today announced it has raised $15 million in a Series B financing round.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InterVene
Sign Up For FreeTo access detailed company insights
InterVene, Inc., located in Redwood City, Calif., in the San Francisco Bay Area, was formed with assistance from the Stanford Biodesign Fellowship program and was a former Company-In-Residence at the Fogarty Institute for Innovation. Staffed by highly experienced interventional cardiovascular professionals and advised by accomplished venous thought... Read More
